US Bancorp
NBRV

US Bancorp’s Nabriva Therapeutics plc Ordinary Shares Ireland NBRV Stock Holding History

US Bancorp’s Portfolio NBRV Stock Details NBRV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-2
Closed – – 4043
2020
Q4 		$0 Hold
2
– – ﹤0.01% 3955
2020
Q3 		$0 Hold
2
– – ﹤0.01% 3931
2020
Q2 		$0 Hold
2
– – ﹤0.01% 3964
2020
Q1 		$0 Hold
2
– – ﹤0.01% 3879
2019
Q4 		$1K Hold
2
– – ﹤0.01% 3624
2019
Q3 		$1K Hold
2
– – ﹤0.01% 3546
2019
Q2 		$1K Buy
+2
New +$1.23K ﹤0.01% 3589

Other funds holding NBRV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
ACM
Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

US Bancorp's NBRV Position: Q1 2021 in Review

US Bancorp sold out of Nabriva Therapeutics plc Ordinary Shares Ireland (NBRV) in Q1 2021, closing a stake of 2 shares.

US Bancorp first reported a position in NBRV in Q2 2019 and held it in 7 quarters. The position peaked at $1K in Q4 2019. 33 funds tracked by Wall St. Rank hold NBRV as of Q1 2021.

  • US Bancorp reported no remaining Nabriva Therapeutics plc Ordinary Shares Ireland position as of Q1 2021 after selling out during the quarter.
  • US Bancorp sold 2 Nabriva Therapeutics plc Ordinary Shares Ireland shares in Q1 2021.
  • US Bancorp first reported a position in Nabriva Therapeutics plc Ordinary Shares Ireland in Q2 2019 and held it in 7 quarters.
  • US Bancorp's Nabriva Therapeutics plc Ordinary Shares Ireland position peaked at $1K in Q4 2019.
  • 33 funds tracked by Wall St. Rank held Nabriva Therapeutics plc Ordinary Shares Ireland as of Q1 2021.

Based on US Bancorp's 13F filing for Q1 2021, filed 28 Apr 2021.